Cargando…
Effect of rifampin with bio-enhancer in the treatment of newly diagnosed sputum positive pulmonary tuberculosis patients: A double-center study
OBJECTIVE: To compare a fixed-dose combination (FDC) of Rifampicin 450 mg, Isoniazid 300 mg, Pyrazinamide 1500 mg and Ethambutol 800 mg (usual care group) and regimen of Rifampicin 200 mg, Isoniazid 300 mg and piperine 10 mg along with Pyrazinamide 1500 mg and Ethambutol 800 mg (intervention care gr...
Autores principales: | Nageswari, A.D., Rajanandh, M.G., Uday, M.K.R.A., Nasreen, R.J., Pujitha, R.R., Prathiksha, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830140/ https://www.ncbi.nlm.nih.gov/pubmed/31720402 http://dx.doi.org/10.1016/j.jctube.2018.07.002 |
Ejemplares similares
-
Effectiveness of vitamin D3 in severe persistent asthmatic patients: A double blind, randomized, clinical study
por: Rajanandh, Muhasaparur Ganesan, et al.
Publicado: (2015) -
Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears
por: Lavania, Surabhi, et al.
Publicado: (2017) -
Effect of vitamin D(3) on mild to moderate persistent asthmatic patients: A randomized controlled pilot study
por: Nageswari, A. D., et al.
Publicado: (2014) -
Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA
por: Heysell, Scott K., et al.
Publicado: (2013) -
Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis
por: Salindri, Argita D., et al.
Publicado: (2016)